Physician profile
Robert Zannella
NPI 1073520912
$3,256.10
in general payments reported to CMS, 2019-2025
34 companies · $399 in 2025
The $399 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $817 · 2020: $458 · 2021: $461 · 2022: $520 · 2023: $317 · 2024: $284 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $999.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $748.88 | 2019-2025 | Jublia, Cabtreo |
| Stryker Corporation | $412.07 | 2019-2025 | Augment Injectable, Prophecy, Prostep Mica |
| Horizon Therapeutics Plc | $407.29 | 2019-2021 | |
| Wright Medical Technology, INC. | $197.45 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $183.49 | 2021-2022 | |
| Boston Scientific Corporation | $145.18 | 2022 | |
| Treace Medical Concepts, INC. | $134.87 | 2022-2025 | |
| Smith+Nephew, INC. | $121.13 | 2019-2025 | Collagenase Santyl, Regranex |
| Sebela Pharmaceuticals INC. | $76.98 | 2020-2023 | Naftin |
| Zimmer Biomet Holdings, INC. | $76.66 | 2020-2021 | |
| Kerecis Limited | $62.26 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Organogenesis INC. | $62.10 | 2020 | |
| 4web, INC. | $53.46 | 2024 | Spine Truss System |
| Sandoz INC. | $52.05 | 2019-2020 | |
| Bioventus LLC | $47.09 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $46.98 | 2019 | |
| Mayne Pharma Commercial LLC | $46.07 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $44.65 | 2022-2023 | Seglentis |
| Convatec INC. | $35.46 | 2023 | |
| Paragon 28, INC. | $31.00 | 2020-2021 | |
| Ani Pharmaceuticals, INC. | $30.62 | 2025 | Purified Cortrophin Gel |
| Alfasigma USA, INC. | $29.23 | 2021 | |
| Merck Sharp & Dohme LLC | $27.20 | 2019 | |
| Orthofix Medical, INC. | $23.68 | 2024 | Physio-Stim |
| Integra Lifesciences Corporation | $23.51 | 2019 | |
| International Rehabilitative Sciences, INC | $21.40 | 2024 | Rs 4i Plus Sequential Stimulator |
| Medshape, INC. | $20.63 | 2023 | Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm |
| Royal Biologics, INC. | $18.15 | 2023 | |
| Novum Pharma, LLC | $17.77 | 2019 | |
| Fidia Pharma USA INC. | $17.16 | 2019 | |
| Linvatec Corporation | $14.62 | 2025 | In2bones USA, 5ms |
| Mimedx Group, INC. | $13.67 | 2024 | |
| Nabriva Therapeutics, Plc | $13.34 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$17,654.29 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Zannella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.